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To my family, to my dearest friends, to my wife, to my son. To those who shaped me 
into who I am. To everyone I love. 
 
Time is never time at all if you can ever leave without leaving a piece of youth.  
And our lives are forever changed, we will never be the same. The more you change the 
less you feel.   








Obesity, defined as an excessive accumulation of body fat, is considered one of the major 
health challenges facing the world today. Adipocyte and lipid turnover determine the number 
and the size of fat cells, respectively. Therefore, understanding the dynamics of adipocyte 
and lipid turnover will provide important insights into the factors regulating the size of the 
fat mass. Adipose tissue is not uniformly distributed throughout the body, and the regional 
differences in turnover may contribute to the link between body fat distribution and increased 
risk of metabolic complications. Several factors such as sex and age are also known to impact 
fat accumulation, however, their influence on adipose tissue turnover dynamics are unclear. 
In this thesis, we provide a comprehensive analysis of age and turnover dynamics of both 
adipocytes and lipids in human subcutaneous (scWAT) and visceral (vWAT) adipose tissue, 
by measuring the integration of 14C derived from nuclear bomb tests into genomic DNA and 
lipids, across the lifespan. The effects of fat mass distribution, sex, age and BMI were 
investigated for their influence on adipose tissue turnover, as well as interventions such as 
weight loss over time. 
 
In Paper I, we examined the differences in lipid turnover in scWAT and vWAT in 
individuals with a range of BMIs. While scWAT lipid age and storage capacity were 
increased in overweight and obese individuals, lipid age in vWAT was increased only in the 
excessively obese individuals and was associated with a reduced lipid removal rate. 
Moreover, in central or visceral obese individuals, lipid turnover was selectively increased in 
vWAT. Metabolically unhealthy obese individuals with small scWAT adipocytes exhibited 
reduced lipid turnover. In conclusion, excess body fat mass results in a depot-specific 
reduction in lipid turnover. Increased lipid turnover in vWAT and/or decreased lipid turnover 
in scWAT may contribute to metabolic complications of overweight or obesity.   
 
In Paper II, we explored lipid turnover dynamics in adults who were followed for up to 16 
years (mean follow-up time 13 years) or 5 years following significant weight loss. Lipid 
removal rate decreased with aging, and a failure to reciprocally adjust for lipid uptake rate 
resulted in weight gain. Substantial weight loss was primarily driven by a reduced rate of 
lipid uptake. Surprisingly, individuals with a low baseline lipid removal rate were more likely 
to maintain the weight loss 5 years following weight-loss surgery. Taken together, these 
findings identify lipid turnover as an important regulator of long-term obesity development 
and weight loss maintenance. 
 
In Paper III, we compared the age of adipocytes and lipid in human scWAT and vWAT. 
vWAT adipocytes were found to be older than scWAT adipocytes, suggesting regional 
differences in the adipocyte death rate. Subject sex, age and body fat mass also had a 
significant impact on adipocyte age. Females had a slower death rate of adipocytes than males, 
and age and BMI inversely correlated with the adipocyte death rate. Lipid removal rate was 
also found to be lower in females than males, and decreased with aging in both depots. In 
 
 
summary, these results identify adipocyte and lipid removal rates as important factors 
contributing to regional differences in fat distribution, and that sex, age and BMI-dependent 
differences in turnover dynamics influence one’s risk developing obesity-associated 
metabolic complications.  
 
Taken together, this thesis provides a deeper characterization of adipocyte and lipid age and 
turnover dynamics in humans. Furthermore, it highlights regional differences in adipocyte 
and lipid turnover and the important link to total fat mass accumulation and distribution, in 
both lean and obese individuals, females and males, and the young and the elderly.  
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1.1 Obesity and adipose tissue 
 
1.1.1 Obesity: a global health issue  
Obesity is a noncommunicable and preventable disorder defined by excessive body fat 
accumulation and impaired health. Rates of obesity are increasing to epidemic proportions in 
most countries and obesity now represents a major worldwide health challenge1. Body mass 
index (BMI) is a simple and commonly used index of weight-for-height to classify normal 
weight, overweight, and obesity in adults. According to the World Health Organization (WHO), 
normal weight is defined as a BMI of less than 25 kg/m2, overweight as 25 to 29.9 kg/m2, and 
obesity as equal or higher than 30 kg/m2. In 2016, an estimated 1.9 billion adults worldwide 
were classified as overweight and, of these, over 650 million were obese. These numbers have 
nearly tripled since 1975. If the current trend continues, an additional 20% of people will be 
obese by 20302, 3. Obesity is linked to an increased risk of disease, such as diabetes, fatty liver 
disease, and cardiovascular disease, which together are referred to as the metabolic syndrome4-
7. Due to the vast number of obesity-associated pathologies, the need to advance our 
understanding of body fat mass regulation is growing.   
 
1.1.2 Adipose tissue architecture 
Adipose tissue is composed of several different cell types (Figure 1.1). Mature adipocytes, the 
lipid-storing cells, are the predominant cell population and are distinct both morphologically 
and functionally, from the other cell types in adipose tissue. Mature adipocytes are further 
divided into three types by based on their distinct functional and structural properties: white, 
brown, and beige. White adipocytes which make up the majority of the volume and weight of 
white adipose tissue (WAT), act as the main energy storage site and endocrine centre. White 
adipocytes have a large unilocular lipid droplet which occupies 95% of the cell volume and 
thereby determines the cell size, ranging from 20 to 200µm in human. Brown adipocytes are 
smaller, mitochondria-rich, and contain multilocular lipid droplets. They are specialized to 
dissipate energy by heat generation through the action of the brown adipose tissue-specific 
protein, uncoupling protein-1 (UCP-1), in the mitochondria. Beige adipocytes have gained 
recognition more recently and remain controversial. While some suggest they arise from a 
unique progenitor population8, other evidence indicates that they may be trans-differentiated 
from white adipocytes9. Beige adipocytes share some similar characteristics of brown 
adipocytes, such as the ability to dissipate heat, and thus are also of interest as an anti-obesity 
therapeutic target to burn rather than store energy9. While brown and beige fat remain 
therapeutically interesting, by far the majority of fat in the human body is white fat, which 






Figure 1.1. Major cell types in white adipose tissue. 
 
In addition to mature adipocytes, WAT is composed of multiple cell populations including 
endothelial cells, smooth muscle cells, macrophages, pericytes, and adipocyte progenitors (APs) 
– collectively called the stromal vascular fraction (SVF). The SVF was isolated for the first 
time by Rodbell in 1964 using collagenase digestion and centrifugation, thereby advancing the 
knowledge of adipose tissue composition and physiology10. Building on this method for 
separating adipocytes from the SVF, Hollenberg et al. used the incorporation of tritiated 
thymidine into the genomic DNA of the SVF to identify the source of newly generated mature 
adipocytes11. The finding that an adipogenic progenitor population resided within the SVF laid 
the path for the extensive research into the regulation of WAT expansion. Because mature 
adipocytes are considered to be post-mitotic and no longer able to proliferate in vivo, the 
recruitment of newly formed adipocytes is believed to originate solely from the proliferation 
and differentiation of these APs12. Studies have explored the molecular signature of white APs 
in mice and the niche in which they reside13, 14. A subset of SVF cells intimately associated with 
the adipose vasculature were defined as the “adipose stem cells”12. Similarly, studies by 
Zimmerlin et al. suggested that pericytes resident in adult human WAT constitute the AP 
population15. This supports the concept that mature adipocytes arise from progenitors residing 
in the adipose tissue SVF.  
 
Adipose tissue is distributed throughout the body in regions described as subcutaneous (scWAT) 
or visceral (vWAT). The major depots of scWAT include abdominal, truncal, gluteo-femoral 
and mammary subregions. vWAT includes omental, mesenteric and retroperitoneal depots.  
 
1.1.3 Adipose tissue function 
Adipose tissue is a complex and multicellular organ that influences the function of many organs 
throughout the body via the release of metabolites and adipokines. Historically, the essential 
function of WAT was considered thermal insulation, mechanical protection and energy storage 
/ release. Based on hormonal and energetic cues, the adipose tissue acts as a site for triglycerides 
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(TG) storage by lipid uptake and esterification, or a source of free fatty acid (FFA) released by 
lipolysis. Since the beginning of the 1990s, there has been a profound shift in the way we view 
adipose tissue due to the discovery of a number of potent adipokines such as leptin, tumor 
necrosis factor alpha (TNF-𝛼) and adiponectin9, 16-18. Over 600 adipokines have been described 
in different proteomic reports and adipose tissue is now considered to be an important endocrine 
organ16-18. While most adipokines exert their effects locally on the adipose tissue itself via 
paracrine signalling, others have endocrine function and are released into the circulation and 
act on distant tissues19-22. The release of leptin, which suppresses appetite via the hypothalamus 
and increases thermogenesis via sympathetic nerve activity, exemplifies how adipokines impact 
energy balance and body weight23.  
 
1.1.3.1 Lipogenesis and lipolysis 
The primary function of white adipocytes is to act as lipid-storing cells. Lipogenesis is the 
process of energy storage in the form of TG, by utilizing fatty acids mainly derived from meals. 
When energy is in excess, TGs are synthesized by the intestine and liver and packed as 
lipoproteins and transported to adipose tissues. TGs are hydrolysed into non-esterified fatty 
acids (NEFA) via the action of lipoprotein lipase (LPL) in adipose endothelial cells. NEFA then 
enters adipocytes where they are subsequently esterified and stored24, 25. Whilst most stored 
lipids come from exogenous fatty acids, fat cells are capable of synthesising lipids from 
carbohydrates via de novo lipogenesis (DNL). Generally, DNL includes i) fatty acid synthesis 
from acetyl-CoA through the action of acetyl-CoA carboxylase (ACC), and ii) TG synthesis, 
where fatty acids and glycerol 3-phosphate form TG26-28.  
 
The removal of fatty acids from adipocytes is a stepwise catabolic reaction termed lipolysis. 
The lipolytic machinery consists of three major enzymes. Firstly, adipose triglyceride lipase 
(ATGL) hydrolyses TG into diacylglycerol (DAG) and one NEFA. In the second step, 
hormone-sensitive lipase (HSL), which displays hydrolase ability towards both TG and DAG 
but is preferential to the latter, converts DAG into monoacylglycerol (MAG) and one NEFA. 
Monoacylglycerol lipase completes the process by hydrolysing MAG to generate glycerol and 
the third NEFA29, 30. Overall, the stored TGs are hydrolysed into NEFAs and glycerol and 
released into the circulation. Circulating fatty acids are taken up by other tissues under energy 
demand and utilized for ATP generation through 𝛽-oxidation. The excess FFAs travel back to 
the liver to be used as a source of very low-density lipoprotein (VLDL) production31. However, 
some FFAs do not leave the adipocytes, or are directly taken up by the adjacent adipocytes, 
termed direct FA uptake, to reform TGs32, 33. The steps of lipogenesis and lipolysis are 
summarised in Figure 1.2.  
 
Both lipogenesis and lipolysis occur in response to various hormones and energy balance cues. 
Insulin upregulates lipogenesis by facilitating glucose uptake as the source of DNL as well as 
enhancing the expression and activity of LPL in adipose tissue34, 35. Although adipocytes 
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perform a basal level of lipolysis, this process is largely driven by	𝛽-adrenergic signalling. 
Catecholamines, such as epinephrine and norepinephrine, bind to 	𝛽 -adrenergic receptors 
(ADRB1 and ADRB2) on the adipocyte cell membrane to promote cAMP production and 
protein kinase A (PKA) activation. PKA phosphorylates rate-limiting HSL which in turn 
initiates the lipolytic process29, 36. Whilst facilitating lipogenesis, insulin also acts as an 
antilipolytic hormone, inhibiting ATGL and HSL activities37-39. Other mediators, such as TNF-
𝛼 , glucocorticoids and natriuretic peptides, also have physiological influences on lipid 

















Figure 1.2. A brief schematic representation of lipogenesis and lipolysis in adipocytes.  
 
1.1.4 Depot-specific differences 
WAT develops in different body locations and exhibits remarkable heterogeneity in cellular 
composition, tissue function and response to hormones. These differences may be due to the 
intrinsic characteristics of WAT depots (e.g. differences in AP gene signature and 
differentiation capacity) but also the unique microenvironment of each depot, such as its 
innervation and circulation41, 42. Although vWAT only accounts for about 20% of total body fat, 
its venous drainage flows into the portal circulation and immerses the liver with its metabolites 
and adipokines, making vWAT strongly linked to an adverse metabolic profile. On the other 
hand, because scWAT can expand outward with minimal anatomic constraint, it serves as a 
sink to store potential cytotoxic fatty acids and has less, or even an inverse, correlation with 
metabolic disease43-45. As such adipose tissue in these regions is now recognized as 
physiologically distinct. Obese individuals who preferentially store excess lipids in vWAT have 
a higher risk for metabolic diseases than those with a similar BMI but who accumulate lipid in 






























complications is not solely dependent on the amount of total body fat, but also regional body 
fat distribution and the ability of scWAT to expand41, 45.  
 
1.1.4.1 Cellularity and morphology 
Despite notable inter-individual variation, adipocyte size is generally smaller in vWAT than 
scABD, although the difference becomes less obvious in obese individuals42, 46. The SVF 
accounts for approximately 50% of total cell number in WAT47. SVF density is higher in 
omental (OM) fat, one of the major visceral fat depots, compared to the subcutaneous 
abdominal (scABD) fat depot48, 49. However, there are more SVF cells in scABD as it is larger 
in tissue size than the OM fat depot in normal-weight individuals under physiological condition.  
Moreover, not only is AP cell number higher, but proliferation and differentiation abilities are 
also higher in scABD than OM depot48-51.  
 
1.1.4.2 Lipid metabolism 
WAT stores more than 95% of total lipids, and the uptake and release of FAs are highly 
regulated in a depot-specific fashion. FA uptake from meals, as well as direct FA uptake, were 
shown to be higher in the OM fat depot compared to the scABD fat depot per unit fat mass52-54. 
LPL activity, the key element for lipid uptake and TG synthesis, was shown to be higher in 
scWAT than OM fat with an exception in obese men55, 56. With higher lipolytic 𝛽-adrenergic 
receptor expression and lower insulin-induced antilipolytic sensitivity56-59, OM adipocytes 
exhibit more of a lipolytic-prone status compared to scABD. Taken together, these differences 
in lipid metabolism contribute to the variation in preferential lipid storage sites60, 61. 
 
1.1.4.3 Adipokine secretion 
WAT secretes different hormones and bioactive molecules that exert their effects in an auto-, 
para-, and endocrine manners to regulate systematic metabolism. Leptin and adiponectin are 
the most studied adipokines, which regulate appetite, lipid metabolism, immune function and 
reproduction42, 62. There are depot-specific differences in adipocyte protein production also. For 
instance, the expression of proinflammatory adipokines, including IL-6, IL-8 and MCP-1, are 
higher in vWAT60, contributing to the link between visceral adiposity and metabolic health. 
Omentin, which acts as an insulin action modulator, is a visceral specific adipokine which is 
only synthesized and released by the OM depot63.  
 
1.2 Fat mass regulation 
 
1.2.1 Adipose tissue expansion 
One of the features that makes WAT a unique organ is its remarkable plasticity. WAT changes 
its mass by regulating the size and/or the number of adipocytes. During a state of overnutrition, 
two mechanisms are involved in WAT expansion: the enlargement of fully differentiated 
adipocytes, termed hypertrophy; and the proliferation and differentiation of APs, termed 
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hyperplasia. In principle, WAT first expands by increasing adipocyte size until they reach a 
critical threshold of lipid-filling. The “full” adipocytes release signals that induce AP 
proliferation/differentiation to accommodate the excess lipid influx64. Previous studies have 
reported a linear-curve relationship between adipocyte volume and body fat mass, 
demonstrating that increases in fat mass cannot be explained by an increase in adipocyte volume 
alone. The nature of the curve suggests the increase in adipocyte number occurs in the later 
stage of obesity development65-67 (Figure 1.3). The precise timeline of the fat mass expansion 
mechanisms during overfeeding, however, remains unclear. As an individual continues to gain 
weight, scWAT, the main fat storage site, can no longer store more lipid through increasing 
adipocyte size or number, and ectopic lipid deposition occurs. Ectopic lipid deposition in non-
scWAT tissues such as vWAT, skeletal muscle, liver and pancreatic beta cells has lipotoxic 
effects, including insulin resistance, inflammation and apoptosis42, 68, 69. Similarly, 
lipodystrophy, defined as the inability to store lipids in scWAT, can also lead to ectopic 
deposition and a similar metabolic outcome as in obesity42, 70.  
 
The mechanism of fat mass expansion has an impact on metabolic profile. Increased adipocyte 
size is associated with other risk factors for type 2 diabetes, such as insulin resistance and 
glucose intolerance, independent of fat mass or distribution67, 71-73. Using the linear-curve 
relationship between adipocyte volume and body fat mass, Arner et al. defined a “relative 
morphology value” as the difference between the measured mean adipocyte volume and the 
expected adipocyte volume for any given body fat mass74. Individuals with positive 
morphology values are categorized as undergoing hypertrophic expansion, whereas individuals 
with a negative value are considered hyperplastic (Figure 1.3). Furthermore, the authors 
showed that women with hypertrophic expansion had a more adverse metabolic profile than 
women with the same body fat mass level but who exhibited hyperplastic expansion. In line 
with this study, others have reported that WAT from individuals with metabolic syndrome is 
characterized by hypertrophic adipocytes, hypoxia, apoptosis and inflammation, and associated 
with abdominal obesity, insulin resistance, and ectopic lipid deposition75-78. On the other hand, 
WAT from metabolically healthy individuals had a higher vessel density with relatively small 
adipocytes75-79 (Figure 1.3), indicating hyperplastic expansion may be a relatively protective 
expansion mechanism. Interestingly, one study reported that the loss of both upper and lower 
body scWAT mas was only attributed to a reduction in adipocyte size, not number80. The 
precise timeline of fat mass change mechanisms during weight gain and loss warrants further 
long-term longitudinal studies.  
 
1.2.2 Depot-specific fat mass expansion and determinants of fat mass and fat 
distribution 
Total fat mass and BMI positively correlate with cardiometabolic diseases, however, body fat 
distribution better predicts metabolic complications and is of clinical relevance41, 45. Different 
adipose tissue depots are distinct with respect to their cellular composition and function and 
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therefore play unique roles in metabolic control. Overnutrition leads to adipose tissue 
enlargement in both scWAT and vWAT. However, vWAT depots reach their expansion 
limitation early in the development of obesity, while scWAT depots grow steadily as obesity  
 
Figure 1.3. Hypertrophic versus hyperplastic fat mass expansion (Figure adapted from Hepler 
et al., 2016)81. 
 
develops82. Individuals with central obesity, or apple-shaped obesity, accumulate excess fat in 
the abdominal region, especially vWAT, and have a higher risk for cardiometabolic disease, 
such as atherosclerosis and diabetes41, 83. On the contrary, lower body or pear-shaped obesity, 
where individuals preferentially store fat in the gluteofemoral areas, is associated with lower 
risk, or even protection, from metabolic disease84, 85. The different outcomes of regional fat 
accumulation may be attributed to differences in depot-specific fat mass expansion mechanisms. 
vWAT generally expands through an increase in adipocyte size, whereas scWAT enlarges by 
both an increase in fat cell size and number41, 86. This greater expandability, which may result 
from the greater proliferation and differentiation capacities of APs in scWAT depots, may 
explain the protective role of scWAT41, 50, 86. However, scWAT depots are not all uniform. 
Gluteofemoral fat tends to expand in a relatively hyperplastic manner during short-term 
overfeeding, whilst upper body scWAT expands via hypertrophy86, thereby explaining the 
better metabolic outcomes of a pear body shape. Taken together, the adipogenic capacity of 
APs in scWAT leads to greater expandability potential, enabling scWAT to act as a protective 
lipid storage sink to minimize ectopic lipid deposition in vWAT and other ectopic sites.  
 
Sex differences in fat distribution, adiposity, and lipid metabolism add another layer to the 
complexity of fat mass regulation. Females generally have higher levels of adiposity and 
primarily store lipid in scWAT depots (especially in the lower body) whilst males have more 
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lean mass but preferentially accumulate fat in visceral depots. This makes sex itself a strong 
predictor for metabolic disease risk87-90. The factors regulating sexual dimorphism have not 
been fully elucidated. Studies have shown that sex-dependent total fat mass and fat mass 
distribution differences diminish at later stages in life, as vWAT mass increases in 
postmenopausal women91. Moreover, women with polycystic ovary syndrome, characterized 
by a hyperandrogenic state, frequently exhibit abdominal obesity92. These results have brought 
much attention to the important role that sex hormones play in fat mass regulation, however, 
the mechanisms involved remain unclear. Additional factors are also likely involved given that 
sex-dependent differences are already present before puberty93. By using the “four core 
genotypes” mouse model, Chen et al. showed that the number of X chromosomes also 
contributes to the sexual dimorphism. In this model, mice were gonadectomized to remove the 
effects of gonadal hormones while maintaining an XX or XY sex chromosomal identity. The Y 
chromosome, more specifically, the Sry gene located on the Y chromosome, initiates 
differentiation of the testes. Mice that have a Sry-deleted Y chromosome (XY-) develop ovaries, 
rather than testes. Conversely, an Sry transgene inserted onto an X chromosome is sufficient to 
convert XX female mice to gonadal males. By these four genotypes, the authors reported that 
mice with two X chromosomes had up to two-fold higher adiposity, regardless of the gonadal 
sex, compared to mice with XY chromosomes. They further produced mice carrying XO and 
XXY chromosome complements and revealed that the adiposity difference between XX and 
XY is attributed to the number of X chromosomes rather than the effect of the Y chromosome94. 
This result suggests that a subset of protein-coding genes, which are located in the X 
chromosome, may contribute to sex differences in fat mass regulation and represent candidates 
for future studies into factors impacting adiposity.  
 
The amount and distribution of adipose tissue also changes throughout life. In general, fat mass 
increases with advancing age due to a chronic positive energy balance, reduced physical activity 
and lower metabolic rate. The increase in fat mass is more pronounced in the abdominal region, 
where males persistently accumulate fat, while females shift their preferential lipid storage site 
from lower body fat depots to abdominal depots95, 96. These age-related alternations in body fat 
mass and distribution lead to a higher risk of metabolic complications in the elderly, including 
ectopic lipid deposition, insulin resistance and chronic systematic inflammation97, 98. 
Understanding the determinants of adipose tissue expansion and distribution, such as sex and 
age, and the underlying mechanisms will provide targets for developing novel therapeutic 
approaches which better address obesity-associated metabolic complications.  
 
1.2.3 Adipose tissue turnover in the regulation of fat mass and fat distribution 
Body fat mass is determined by the number and size of adipocytes. The balance between the 
proliferation and differentiation of APs into mature adipocytes and the death rate of existing 
adipocytes determines adipocyte number. If the generation rate is higher than the death rate of 
adipocytes, fat cell number grows. Similarly, the storage and removal rates of lipid within 
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adipocytes control adipocyte size. An increase in adipocyte size occurs when the lipid storage 
rate is higher than the removal rate. Therefore, the balance between synthesis and breakdown 
(i.e. turnover) of adipocytes and lipids is crucial for fat mass regulation (Figure 1.4).  
 
Cross sectional studies in humans have shown that both adipocyte size and number increase 
during childhood and adolescence but that the number reaches a plateau and remains constant 
afterwards65, 66. Individuals obese since childhood, however, may have twice the number of 
adipocytes prior to adulthood than lean individuals65. Longitudinal studies, where individuals 
with or without weight change are followed for many years, will provide important insight into 
how adipocyte number changes throughout life. Short-term weight change studies, however, 
also provide insights into how adipocyte number is regulated. Salans et al. reported that only 
fat cell size, not number, changed in scWAT depots in healthy non-obese men during 3 - 4 
months of weight gain and subsequent weight loss periods, supporting the conclusion of a tight 
regulation of adipocyte number in adulthood99. Total adipocyte number in this study was, 
however, calculated as total body fat mass divided by average adipocyte size across three 
scWAT depots. By pooling adipose depots, subtle yet significant differences in fat cell number 
as a function of weight gain and loss, may have been lost46.   
 
Figure 1.4. Adipocyte and lipid turnover regulate adipocyte number and size.  
 
In a more recent study, the regional differences in fat mass expansion in women following an 
eight-week period of weight gain were revealed. Here the authors demonstrated that an increase 
in adipocyte number only occurred in lower body fat, but not in the scABD depot86. In a similar 
experimental setting, Singh et al. reported that adipocyte number remained constant after a 
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period of weight loss80. These results concur with other studies that show once a higher 
adipocyte number is established, weight loss does not result in a loss of gained fat cells65, 
leading people to propose a “thrifty genotype” theory. The “thrifty genotype” theory suggests 
that humans have gone through a positive evolutionary selection for genetic mechanisms that 
favor energy storage to survive ancient times of famine. The combination of the modern 
sedentary lifestyle, plus long-term overnutrition, now contribute to the obesity epidemic we 
face today100, 101. 
 
Regional differences in adipose tissue lipid kinetics may contribute to the depot-specific 
differences in adipocyte size. As mentioned above, mean adipocyte size in the scABD depot is 
larger than the OM depot in general. In support of this, studies have shown that OM adipocytes 
not only exhibit greater responsiveness to lipolytic adrenergic agonists in both sexes due to 
higher ADRB1 and ADRB2 expression56-58, they are also less sensitive to the antilipolytic effect 
of insulin59. Taken together, these characteristics push OM adipocytes into a lipolytic state and 
increase FA efflux via the portal vein to the liver, contributing to the adverse metabolic effect 
of the OM depot56-58. Other factors, such as sex, are also involved in lipid metabolism and 
adipocyte size regulation through complex interactions102. For instance, men have larger 
adipocytes, especially in vWAT depots, than women but this size difference diminishes in obese 
individuals58, 103 (reviewed in Ref. 100). 
 
1.3 Current knowledge of human adipose tissue turnover dynamics 
 
1.3.1 Methods to study cell and lipid turnover 
Due to ethical and technical difficulties in studying cell turnover in humans, most of our 
understanding of cell turnover is translated from animal studies. This is often from rodents, 
which may not be an ideal model for humans who can live for up to a century and potentially 
have a greater need for cell replacement throughout the life span. Traditional methods often 
involve the detection of cell proliferation markers such as Ki-67, phospho-histone H3 (PHH3) 
and proliferating cell nuclear antigen (PCNA)104-106. Although these methods provide good 
estimates of the number of cells in cell cycle at a given point in time, they fail to give 
information concerning the fate of the labeled cells and offspring. Whether the progeny will 
mature and integrate into tissues, or when the labeled cells were born cannot be concluded. 
Another strategy to estimate cell generation is via the administration of labeled nucleotide 
analogues, such as 3H-thymidine, 5-bromo-2'-deoxyuridine (BrdU) and 5-ethynyl-2'-
deoxyuridine (EdU), which are incorporated into newly synthesized DNA during S-phase107, 
108. These prospective labeling methods have been useful for revealing cell generation in 
experimental animal models. It is, however, difficult to detect rare events (i.e. cells with slow 
turnover) and their use in humans is limited due to potential cytotoxicity of labeled nucleotides 
for long-term chasing. Meanwhile, most of the lipid metabolism studies that have provided 
important insights into lipid biology have been performed using adipose tissue biopsies in in 
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vitro environments. The interpretation of these studies is hampered by the absence of the 
WAT’s natural milieu, for instance, the local adipocyte production of the antilipolytic 
compound, adenosine109. Hence, in vivo approaches are necessary to accurately investigate 
adipocyte and lipid turnover mechanisms. 
 
Ravussin and colleagues assess both adipocyte and lipid turnover kinetics in vivo by measuring 
the short-term (8 weeks) incorporation of the stable isotope deuterium from heavy water (2H2O) 
into adipocyte DNA and lipid110-112. While these studies provide powerful insights into 
understanding adipose tissue turnover during different interventions, such as dietary or 
pharmacological treatments, over short time periods, they do not give information over the 
lifetime of an individuals. Retrospective 14C dating, a method developed recently by our group, 
provides information regarding long-term cell turnover dynamics by analyzing the integration 
of 14C derived from nuclear bomb tests into genomic DNA and lipids65, 113, 114 (for background 
and a detailed description on radiocarbon dating, see Methods 3.1). This method allows for the 
retrospective analysis of adipocyte/lipid turnover in humans across the lifespan of an individual. 
 
1.3.2 Current studies addressing in vivo measurement of human adipose tissue 
Studies have shown that early phases of overfeeding or weight loss in adults predominantly 
modifies the size of adipocytes and not the number80, 99. For decades, such observations 
supported the notion that adipocytes are terminally differentiated, non-turning over cells, which 
respond to nutritional changes only by regulating lipid storage and removal. Whether mature 
adipocytes were generated from progenitor cells in adulthood was unknown. Work in the Arner 
and Spalding laboratories, however, showed that while adipocyte number in adults may remain 
constant, there is a continuous turnover of mature adipocytes where the adipocyte generation 
rate matches the death rate65. The estimates of adipocyte turnover in humans vary greatly with 
two different study methods. White et al. assessed adipocyte turnover kinetics in scWAT depots 
via an eight-week incorporation of deuterium (heavy water). They report that approximately 
8% of adipocytes were newly generated during a 8-week labeling period111. Moreover, they 
demonstrated depot-dependent differences in adipocyte generation rate, with higher adipocyte 
formation in the femoral fat depot compared to scABD depot. Notably, the adipocyte death rate, 
an important component of adipocyte turnover, was not measured in this study. However, based 
on the assumption that a person remained weight stable during the experimental period, the 
adipocyte birth rate was likely balanced by the death rate to indicate the adipocyte turnover rate. 
Compared to the rapid adipocyte turnover estimated by the heavy water method, we previously 
reported that approximately 10% of adipocytes in scABD are replaced every year65. The carbon 
dating method measures the age of cells present in the samples and, by extension, their death 
rates. The heavy water method, on the other hand, measures newly synthesized DNA with 
deuterium and thus the adipocyte birth rate. Including newborn adipocytes (i.e. differentiated 
post-mitotic AP), which have a higher turnover rate than mature adipocytes, into measured 
adipocytes may result in an overestimation of adipocyte birth rates (see Supplementary 
 
 12 
Information 3 in Reference 64). Possibly, the 7- to 12-fold difference in the adipocyte turnover 
rates estimated by two methods may represent the excess ratio of APs to mature adipocyte 
generated, indicating that most proliferating APs do not permanently integrate into mature 
adipocyte population. One other potential explanation for these differences is the purification 
of adipocytes isolated from enzymatically digested adipose tissue. Contamination by the highly 
proliferative SVF cells may result in an over-estimation of the adipocyte turnover rate. However, 
we have reported adipocyte purification efficacy by our adipocyte isolation protocol is higher 
than 98%65. In support of the role of adipocyte purity being an important factor in fat cell 
turnover estimates, a recent study by Guillermier et al. adopted the heavy water labelling 
procedure and used multi-isotope image mass spectrometry (MIMS), an image-based method 
with subcellular resolution, to detect deuterium115. The authors reported an approximately 11% 
yearly adipocyte birth rate. This adipogenesis measurements are similar to the 10% turnover 
rate estimated by the carbon dating method, and significantly lower than the birth rates reported 
from the bulk-measurement of heavy water labelled adipocytes. The sensitivity of different 
stable isotope detections may also contribute to these different turnover estimations.  
 
Arner et al. provide direct evidence as to the important role that adipocyte turnover plays in 
different adipocyte phenotypes of the scABD depot74. Although the percentage of adipocytes 
replaced each year was similar in hypertrophic and hyperplastic states, the total number of 
adipocytes generated per year was 70% less in hypertrophic individuals compared to 
hyperplastic individuals. There was also an inverse correlation between adipocyte size and 
adipocyte generation rate (i.e. the higher the hypertrophic degree, the lower the adipocyte 
generation rate). This suggests that a slower generation rate of adipocytes results in existing 
adipocytes accumulating more lipids, leading to adipocyte hypertrophy and the associated 
unfavorable metabolic profile. Strawford et al. also applied the heavy water labeling method to 
measure TG synthesis and turnover. They estimated that the TG half-life was about six months 
in scWAT depots116. By 14C dating method, we further identified that high TG storage, but low 
removal rates contribute to fat mass accumulation and obesity development in the scABD depot.  
 
In summary, prospective and retrospective methods to investigate adipose tissue turnover in 
humans have been established. These estimations, however, do not measure exactly the same 
thing and, as described above, can result in inconsistencies. The advantage of the carbon dating 
method is its ability to determine cell and lipid turnover over the entire lifespan of an individual, 
without the need for administrating labelling compounds. The studies mentioned above have 
assessed only scWAT depots and any information concerning adipose tissue turnover in vWAT 







2. RESEARCH AIMS 
 
2.1. General aim 
 
To provide a comprehensive overview of human adipose tissue dynamics by studying adipocyte 
and lipid turnover, as a product of sex, aging and total fat mass in both subcutaneous and 
visceral fat depots.  
 
2.2. Specific aims 
 
I. To compare lipid turnover in scABD and OM fat depots in subjects with a range of body 
fat masses, and to assess how lipid turnover is altered in individuals with central obesity 
or who are metabolically unhealthy. 
 
II. To investigate how lipid turnover dynamics change over time, following individuals for 
up to 16 years. The role of lipid turnover in weight loss maintenance, 5 years following 
bariatric surgery, was also investigated.  
 
III. To define adipocyte and lipid age in subcutaneous and visceral fat, and examine how 
depot-specific differences in turnover rate associates with body fat mass distribution. 
Furthermore, we investigated whether factors including sex, age and total fat mass 
























The methods commonly used in the constituent studies of this thesis are described here.  
 
3.1. Retrospective 14C dating  
The average age of human adipocytes and lipids was determined by measuring the 14C content 
of adipocyte genomic DNA (cell age) and triglyceride (lipid age), respectively. 14C is the least 
abundant naturally occurring carbon isotope (1 part per trillion of total carbon)113, 117, 118. 
Atmospheric levels have remained relatively stable, with respect to all carbon, for the last 
several thousand years. However, atmospheric detonations of nuclear weapons during the Cold 
War (1955-1963) notably increased the concentration of 14C / 12C in the atmosphere117, 118 
(Figure 3.1). Even though the tests were conducted at specific locations, the increased 
atmospheric 14C rapidly equalized around the globe. Since the signing of the Partial Test-Ban 
Treaty in 1963, atmospheric 14C levels have progressively decreased. The decline, however, is 
not due to radioactive decay, as the half-life of 14C is 5,730 years, but rather is the result of 
atmospheric 14C diffusing into the oceans and the biotope. Atmospheric 14C reacts with oxygen 
to form 14CO2, which is incorporated into plants by photosynthesis. By eating plants, and 
animals that live off plants, the 14C concentration in the human body closely parallels that of 
the atmosphere at any given point in time.  
 
 
Figure 3.1. Schematic illustration depicting the strategy of 14C birth dating.  
 
By assessing the incorporation of 14C into genomic DNA and lipids, it is possible to determine 
the age of a cell population and thus the death rate. 14C is integrated into genomic DNA during 
DNA synthesis. In terminally differentiated cells, that do not undergo further rounds of DNA 
synthesis, 14C levels in the DNA will remain constant and reflects the date the cell was formed. 
Thus, the 14C /12C ratio in DNA acts as a date stamp for when an adipocyte was born. Lipid 
stored in adipocytes, mainly as TG, can also be measured to assess mean lipid age (reflecting 
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the amount of time lipid is resident in the adipose tissue). Such analysis can provide information 
as to the removal rate of lipids from the adipose tissue, as well (if total fat mass is known) the 
amount of lipid stored in the adipose tissue. This allows one to measure the flux of lipids in and 
out of the adipose tissue and indicates whether alternations in lipid fluxes may contribute to 
various metabolic diseases.  
 
In Figure 3.1, the black curve shows the atmospheric 14C levels over the last decades. The peak 
of the curve demonstrates the large addition of 14C during the Cold War. In this example, ① 
shows a person’s date of birth. The pink dot illustrates the 14C data point of a hypothetical 
sample, where the measured 14C concentration is plotted against the date of collection ③. By 
comparing the measured 14C concentration with the atmospheric 14C curve (black dashed lines), 
the average birth year of the hypothetical sample is indicated by ②. The time difference 
between the date of sample collection and average birth date provides an estimate of mean 
adipocyte or lipid age. When the measured 14C value ③ approximates the atmospheric levels 
of the curve, this indicates a contemporary cell or lipid age. Measured values that sit above the 
curve indicate older cells or lipids.  
 
The detection sensitivity for new cell and lipid generation depends on the steepness of the 
atmospheric 14C curve between when an individual was born ① and when the new cells or 
lipids were generated ②. An individual who was born before the dramatic increase in 
atmospheric 14C levels has the highest sensitivity for detecting cell generation due to the largest 
difference in 14C levels between the birth date and the cell or lipid generation date. For instance, 
a measurement in a person who was born 20 years before the increase in 14C will have the 
highest sensitivity for detecting newly generated cells during early adulthood. In contrast, 
measurement from a person born after the atmospheric 14C peak will be most sensitive for 
detecting cells or lipids born more contemporarily. The accuracy of average age estimation, on 
the other hand, depends on the steepness of the atmospheric 14C curve between cell or lipid 
generation date ② and the date of collection ③, as well as error margins resulting from 
measurement error (which depend, for example, on sample handling and sample sizes). The 
detection limit, when comparing time points on the steepest part of the atmospheric 14C curve 
with the current sensitivity of accelerator mass spectrometry, is about 1% newborn cells within 
a population of pre-existing or non-turning over cells. The accuracy, across the atmospheric 14C 
curve, as evaluated by radiocarbon dating human tooth enamel, is on average +/- 2 years113.  
 
3.2. Adipose lipid and adipocyte genomic DNA extraction 
Adipocytes were isolated from whole adipose tissue samples using a collagenase-based 
digestion protocol10 and the purity of the isolation procedure was validated as described 
previously65. Lipid within the adipose tissue is primarily stored in adipocytes, and previous 
work has shown that the 14C-derived lipid age is comparable when extracted from either whole 
adipose tissue pieces or isolated adipocytes114. Therefore, lipids extracted using an 
 
 16 
isopropanol/heptane/H2SO4 protocol119 from either adipose tissue or isolated adipocytes were 
used. The extracted lipid weight constitutes 70 - 80% of the initial sample weight. Adipocyte 
DNA was extracted from isolated adipocytes using the phenol/chloroform/isoamyl alcohol 
extraction protocol described by Liu et al.120, and modified to maximize the DNA yield while 
minimizing non-DNA carbon contamination for 14C dating. DNA was measured and purity 
checked by Nanodrop spectrometer and gel electrophoresis. Potential RNA and protein 
contamination were also assessed by RNA and protein detecting kits. To minimise the 
introduction of exogenous carbon whilst maximizing DNA yield and purity, several steps were 
optimised from the phenol/chloroform/isoamyl alcohol extraction protocol (see Methods in 
Paper III). The extra RNA digestion step and DNA precipitation, rather than the commonly 
used centrifugation-based collection of DNA pellets, was used in this study to improve DNA 
purity, while the second precipitation increased DNA yield. All extraction procedures were 
performed in a carefully cleaned dust-free hood and glassware was prebaked at 450 °C for 4 
hours to avoid the introduction of exogenous carbon. The amount of adipose tissue that is 
required to obtain enough carbon for 14C analysis varies from region to region, depending upon 
fat cell size. Generally, a minimum of 20 grams of adipose tissue is required for adipocyte 14C 
analysis and about 0.1 gram of adipose tissue or isolated adipocytes for lipid 14C analysis. 
 
3.3. Accelerator mass spectrometry 
To estimate the average age of adipocytes and lipids, the amount of 14C in adipocyte genomic 
DNA and lipids was measured by highly sensitive accelerator mass spectrometry (AMS). The 
sensitivity of AMS and the ultra-small sample preparation method required for most biological 
samples, including adipocyte DNA, have improved considerably during the last few decades, 
reducing the required biological sample size from about 1 mg of carbon to less than 10 𝜇g121, 
122. However, single-cell resolution will not be possible given that there is approximately only 
one 14C atom in the genomic DNA for every 15 cells113. 14C levels in cerebellar neuronal DNA 
was also measured as an internal control for adipocyte measurements. Cerebellar neurons 
(isolated from human brain samples collected post-mortem) do not turnover across the 
lifespan113, and as such, the average age of cerebellar neurons should reflect the date when the 
person was born. Specific AMS procedures, d13C measurements and isotopic fractionation 
corrections, were performed as detailed in the constituent papers.  
 
3.4. Mathematical modelling  
Mathematical modelling was applied to estimate the turnover rates of adipocytes and lipids. In 
adulthood many tissues replace lost cells with new ones to maintain homeostasis. However, this 
balance may be different among tissues due to differences in the rate of cell replacement, aging, 
or under physiological/pathological conditions. For instance, a reduced generation rate of 
adipocytes may be compensated for by adipocyte hypertrophy during weight gain, or the lipid 
removal rate may be different between lean and obese individuals. Thus, turnover modelling is 
aimed at explaining the unique turnover dynamics for a given population of cells, or lipid, and 
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involves testing a range of scenarios and fitting these scenarios to experimental data obtained 
from measuring samples that cover the range of the bomb curve. Thus, the aim is to find a 
turnover rate scenario that best explains the measured 14C levels123. The death rate of adipocytes 
represents the fraction of adipocytes replaced each year and is the inverse of adipocyte age (1 / 
adipocyte age). As such, a high adipocyte age reflects a low adipocyte death rate. Similarly, the 
lipid removal rate (Kout) indicates the fraction of lipids replaced each year and is the inverse of 
mean lipid age (Kout = 1 / lipid age). If total fat mass is known, the net lipid intake can be 
determined (Kin = kg of fat mass per year. The amount of lipid in kg stored in the adipose tissue 
each year), reflecting the lipid storage capacity. The modelling methods for adipocytes and 
lipids are described in detail in the constituent papers.  
 
Atmospheric 14C levels across the two hemispheres correlates, but lags in the Southern 
Hemisphere (i.e. the 14C levels in the Southern Hemisphere never reach the same height as the 
Northern Hemisphere at the peak of nuclear testing, but the 14C levels in the Southern 
Hemisphere are slightly higher than those in the Northern Hemisphere in the last decades). For 
samples formed in the last 20 year, this slight shift in atmospheric abundance can produce an 
overestimation of age if samples from the Southern Hemisphere are analysed using the curves 
calibrated from the Northern Hemisphere measurement. We noticed a 6-month to 1.5-year 
difference in estimated ages between Northern and Southern Hemispheres. No published data 
for Southern Hemisphere atmospheric 14C levels after 2006 were available at the time of 
analysis (August 2020). However, we were kindly provided by Quan Hua (ANSTO, Australia, 
personal communication) recent Southern Hemisphere data, running up to the end of 2017. 
Thus, for Northern Hemisphere samples in Paper I and II, we used the Schauinsland dataset124. 



















4. Results and discussion 
 
4.1. Paper I 
Impact of Fat Mass and Distribution on Lipid Turnover in Human Adipose Tissue  
 
4.1.1. Summary of results 
Adipocyte size is determined by the balance between lipid storage (Kin) and removal (Kout), 
termed lipid turnover. Different lipid turnover rates in scWAT and vWAT may contribute to 
depot-specific fat cell size differences, potentially contributing to metabolic complications in 
overweight and obese individuals. A previous study has shown that scABD lipid storage and 
removal rates are altered in obese individuals compared to lean individuals114, although no data 
on vWAT was given. Here we compared lipid turnover rates in scABD and OM fat depots 
across a wide range of BMIs. Associations between lipid age and anthropometry were analysed 
by linear regression. A positive correlation between lipid age and BMI was found in both fat 
depots and waist-to-hip ratio (WHR; higher waist-to-hip value indicates central body fay 
accumulation) also correlated negatively with lipid age, but only in the OM fat depot. Even in 
the significant correlations, this association were weak, indicating that there is no simple linear 
relationship between lipid age and total or regional body fat mass. As such, subjects were 
broken into categories based on BMI, body fat mass, or fat mass distribution, for subsequent 
analyses. 
 
Based on BMI, subjects were broken down into 3 categories; lean, overweight/obese, morbidly 
obese. The mean lipid age in the scABD depot was 0.6 years higher in the overweight/obese 
group compared to lean individuals. No subsequent increase in lipid age was found in the 
excessively obese group (BMI ≥	40 kg/m2). Lipid age in the OM depot was not influenced by 
BMI, except in the excessively obese group, where the lipid age was increased by 0.7 years 
compared to the overweight/obese group. The increase in lipid age with BMI in both depots 
was not influenced by sex. A negative correlation between vWAT lipid age and noradrenaline-
stimulated lipolysis suggested that the lipid removal rate (Kout) primarily reflects 
catecholamine-induced lipolysis in vWAT depot (as reported previously for scWAT114). Taken 
together, lipid turnover remains stable in vWAT over a broad range of BMIs and is only reduced 
in excessive obesity, mainly due to a decreased lipid removal rate. In scWAT, a similar manner 
of reduced lipid turnover was observed, however, it occurred earlier already in the overweight 
state.  
 
To explore the influence of body fat distribution on lipid turnover, subjects were subdivided 
into tertiles based on android/gynoid fat mass or visceral/total fat mass as indications of fat 
distribution. Although android/gynoid and visceral/total fat mass were not correlated with 
scABD lipid turnover, individuals with central obesity (high android/gynoid ratio) or 
pronounced visceral obesity (high visceral/total fat mass ratio) had average 0.7 years younger 
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lipid age and 1 kg/year higher lipid storage rate in the OM fat depot compared to those with 
peripheral obesity or little visceral fat mass. Therefore, central or visceral obesity is linked to 
increased lipid turnover in vWAT. We further investigated the relationship between lipid age 
and body fat distribution by selecting obese individuals where detailed information on scABD 
and vWAT fat mass was known. The subjects were then subdivided into quartiles based on their 
lipid age. Body fat mass and distribution indexes were compared between the groups with the 
highest and lowest quartiles of mean lipid age. This analysis showed that no significant 
difference was found in the scABD depot, whilst a low OM lipid age associated with increased 
WHR and central/visceral fat accumulation.  
 
 
Figure 4.1. Lipid age in different BMI groups in a) scABD and b) OM fat depots.  
 
pronounced visceral obesity (high visceral/total fat mass ratio) had averagely 0.7 years younger 
lipid age and 1 kg/year higher Kin in the OM depot compared to those with peripheral obesity 
or little visceral fat mass. Therefore, central or visceral obesity is linked to increased lipid 
turnover in vWAT. We further tested the relationship between lipid age and body fat 
distribution by subdividing obese individuals according to lipid age in two depots. Body fat 
mass and distribution indexes were compared between the groups with highest and lowest 
quartiles of mean lipid age. We showed that no significant difference was found in the scABD 
depot, while low OM lipid age was associated with increased WHR and central/visceral fat 
accumulation.  
 
To directly investigate regional differences in lipid turnover between the scABD and OM fat 
depots, we compared lipid age in individuals where we were able to obtain adipose tissues 
biopsies from both depots from the same individual. Lipid age was slightly higher (approx. 0.3 
years) and lipid storage rate much higher (approx. 0.7 kg/year) in the scABD compared to the 
OM fat tissue.  
 
Finally, we investigated the relationship between adipocyte size and lipid age in metabolically 
healthy and unhealthy obese individuals. No correlation between adipocyte size and lipid age 
was found. As expected, unhealthy obese individuals had fewer but larger adipocytes in the 
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scABD depot. However, when subjects were grouped based on adipocyte size, lipid age was 
increased only in the small adipocytes of unhealthy compared to healthy subjects. No such 
difference was found in subjects with large adipocytes. 
 
4.1.2. Discussion and future perspectives 
In this study, we showed for the first time that in vivo lipid handling in scWAT and vWAT 
differs in humans. Lipid age in both the scABD and OM depots increased with body fat mass, 
however, with depot-specific traits (Figure 4.1). Results suggested that the scABD depot 
reaches its maximal storage and release capacity already early in the development of obesity, 
which may explain why ectopic lipid deposition in the liver is already observed following only 
a moderate body weight gain in non-obese individuals. In contrast, vWAT maintained a stable 
lipid turnover rate over a wide range of body fat mass, and was only reduced in excessive 
obesity. The reduced lipid turnover rate in both fat depots was mainly attributed to a diminished 
capacity of lipid removal.  
 
Body fat distribution selectively impacts lipid turnover dynamics in the OM depot, and 
central/visceral obese subjects were found to have an increased OM lipid turnover rate. This is 
attributed to a combination of increased capacity to store (Kin) and remove (Kout) lipids. The 
higher vWAT lipid turnover in central/visceral obese subjects may contribute to an increase in 
portal FA fluxes and facilitate the adverse metabolic profile associated with high vWAT mass. 
Moreover, the higher average lipid age of scABD adipose tissue, compared to OM adipose 
tissue, is attributed to a higher lipid storage capacity, and could be an important reason why 
scWAT serves as the main lipid storage site in obesity.   
 
One would expect that unhealthy obese individuals with fewer, larger scABD adipocytes would 
have a lower lipid turnover (and thus higher lipid age). However, this was not the case, as we 
observed reduced lipid turnover only in unhealthy obese individuals with relatively small 
adipocytes. This suggests that ectopic lipid deposition may not solely result from an insufficient 
increase in scWAT adipocyte size and/or number (i.e. in unhealthy obese subjects with fewer 
but large adipocytes) but also a diminished capacity for lipid turnover before adipocytes reach 
their maximum storage capacity. 
 
Our study has some limitations. Firstly, we only investigated Caucasians and as such racial 
variations in regional lipid turnover cannot be ruled out, and should be explored before broad 
statements about depot differences in humans can be concluded. Secondly, the femoral fat depot 
has been shown to be protective from the metabolic complications of obesity42, 86. We did not 
sample adipose tissue from this depot as the study was designed long before this information 
was available. Extreme diets, such as exclusive marine diets, may lower the intake of 14C 
incorporated into lipids. However, after the year 2000, when most of the samples were collected, 
the atmospheric 14C levels have been low, implying the effects of exclusive marine diets would 
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be negligible125. In addition, these diets in urban Sweden (where included subjects were 
recruited) are rare. 14C content differs between fresh and frozen food products, resulting in a 
"food lag". We show that mean lipid age is significantly older than blood taken from the same 
individuals, suggesting that estimated lipid age is not merely a result of a food lag. Of note 
however, these methodological issues are less relevant as this study was focused on intra-
individual comparisons of scWAT and vWAT. 
 
In summary, scWAT has a greater storage capacity than vWAT, but attains its maximal level 
as early as in the overweight state, which may increase the risk for lipid spill over and ectopic 
fat deposition in obesity. Body fat distribution only impacted on vWAT lipid turnover, where 
both lipid storage and removal rates were increased in central/visceral obesity. This helps 
explain the strong link between central body fat accumulation and metabolic complications. 
Finally, inappropriate scABD lipid handling in small adipocytes may be a determinant of an 
unhealthy obese phenotype. However, further studies combining detailed clinical phenotyping 
with regional lipid turnover measurements are needed to confirm the role of regional lipid 



























4.2. Paper II 
Adipose Lipid Turnover and Long-term Changes in Body Weight 
 
4.2.1. Summary of results 
Cross-sectional studies have shown that lipid removal rate decreases in obesity114, 126. Whether 
lipid turnover is constant over our life span or changes during long-term weight change is 
unknown. We performed a longitudinal investigation, following subjects for up to 16 years, to 
elucidate whether there are changes in lipid turnover during aging. In a different cohort, we 
followed patients for 5 years after significant weight loss by bariatric surgery. 
 
In cohort 1, lipid age in scABD increased significantly by 0.6 years over an average timespan 
of 13 years, despite large inter-individual variation. Lipid age did not correlate with subject age. 
Furthermore, increased lipid age over time (Δ lipid age), which reflects a decreased in lipid 
removal rate, was not correlated with a subject’s starting age. Body weight change over time 
and Δ lipid age were not correlated, with the Δ lipid age not differing between weight gainers 
(≥7% weight gain) and weight losers (≥7% weight loss). Taken together, the lipid removal rate 
in scWAT slows down in adults with age. This reduced lipid removal rate leads to an 
accumulation of body fat over time unless compensated by a decrease in lipid uptake (by proxy, 
food intake). Individuals with no change in lipid uptake during the examination period 
demonstrated approximately a 20% increase in body weight (Figure 4.2, where the regression 
line crosses zero). Other factors, such as physical activity and dietary composition, may also 
influence lipid accumulation in WAT127, 128. However, there was no correlation between lipid 









In cohort 2, we investigated severely obese individuals who underwent gastric bypass surgery. 
These patients demonstrated a significant and sustained decrease in BMI over 5 years after 
surgery. However, no change in lipid age was found, indicating that weight loss was not driven 
by an alteration in the lipid removal rate. There was a significant decrease in lipid uptake (Kin) 
5 years after surgery, suggesting net lipid uptake is the main determinant driving weight loss 
following surgery. Notably, we showed a significant correlation between weight loss over 5 
years (Δ BMI) and lipid age at year 0, with the largest Δ BMI observed in patients with the 
highest initial lipid age, independent from initial BMI. When patients were grouped into tertiles 
based on their ability to maintain weight loss 5 years post-surgery (weight rebounders, tertile 1 
or weight-stable, tertiles 2 and 3), the only parameter that correlated with weight stability during 
5 post-surgery years was lipid age prior to surgery (t = 0). Surprisingly, lipid age was highest 
at t = 0 in the weight-stable patients compared to weight rebounders. (Figure 4.3 a and b). 
Although average lipid age remained unchanged across all tertiles, if weight-stable and weight 
rebounding individuals were examined separately (i.e. tertile 1 versus tertiles 2 and 3), lipid age 
decreased in the weight-stable patients and increased in the weight rebounders, suggesting that 
decreased lipid age, and therefore increased lipid removal rate, following substantial weight 
reduction contributed to successful weight loss maintenance. 
 
 
Figure 4.3. a) BMI at year 0, 1, 2 and 5, with patients divided into weight rebounders (tertile 1) 
and weight stable (tertiles 2 and 3) groups based on the change in BMI between years 2 to 5. b) 
Initial lipid age (at year 0) between weight rebounder and weight stable groups.  
 
As age- and weight-related changes in lipid turnover may lead to compensatory ectopic lipid 
deposition in the liver from vWAT, we assessed fatty liver index and total vWAT mass in a 
second cohort. No association between lipid age change over time and fatty liver index or 
vWAT mass was observed. It has been shown that increased adipocyte size leads to adipose 
inflammation and impaired lipid storage and removal capacities81. In both cohorts, adipocyte 
size decreased while adipocyte number increased, therefore supporting the hypothesis that a 




As energy expenditure and lipid oxidation also regulate fat mass, we compared lipid age with 
results from indirect calorimetry at baseline in both cohorts. Neither resting energy expenditure 
nor respiratory quotient correlated with lipid age, suggesting lipid removal rate is another 
important and independent regulator of body fat mass.      
  
4.2.2. Discussion and future perspectives 
Previous studies have shown that the major driver for obesity is calorie intake, not energy 
expenditure129. Our results add an extra dynamic to this energy balance theory.   
 
In cohort 1, we found a reduction in lipid removal rate over time leads to weight gain unless 
compensated for by reducing caloric uptake. In cohort 2, we showed that lipid age prior to 
weight loss was higher in the weight-stable group compared to weight rebounders. This 
indicates that individuals with a lower lipid removal rate before weight loss may have larger 
window for increasing their lipid removal, compared to those with already higher removal rates 
before weight loss. Therefore, lipid removal rates may influence the maintenance of weight loss 
and therefore be an important determinant for long-term weight loss.  
 
Although currently there is no pharmacological agent targeting lipid turnover in adipose tissue, 
it is possible to modify catecholamine-induced adipocyte lipolysis, which plays a central role 
in lipid removal rate and lipid age. For instance, endurance exercise training enhances adipocyte 
lipolytic activity127, 130. Sympathoadrenal activity decreases with age and may result in a slowed 
lipid turnover rate131. In line with this, catecholamine-induced lipolysis in vivo is impaired in 
elderly individuals and could be a potential target for obesity treatment. In summary, this study 



















4.3. Paper III 
The Dynamics of Fat Cell and Lipid Turnover in Omental and Subcutaneous Adipose 
Tissue in Adult Humans 
 
4.3.1. Summary of results 
Despite the strong link between visceral adiposity and metabolic disease, little is known about 
adipocyte turnover and how it associates with fat accumulation in vWAT. To investigate 
whether differences in adipose tissue turnover, including both adipocyte and lipid, contribute 
to regional differences in the distribution of body fat, we examined the age of fat cells and lipids 
from the scABD and OM depots in paired biopsies from the same individual. 
 
The average age of OM adipocytes was 10.9 ± 5.4 years (mean ± s.e.m.). This was significantly 
older than that measured for scABD adipocytes (8.6 ± 4.4 years), which is in line with our 
results for a previous study65. There was a significant positive correlation between scABD and 
OM adipocyte age; such that if subjects had a high adipocyte age in the scABD depot, they 
were also likely to have a high adipocyte age in the OM depot. Apart from regional differences, 
using multivariate regression analysis we also found that a subject’s age, sex and BMI 
significantly and independently influenced average adipocyte age and thus the adipocyte death 
rate. Average adipocyte age increased with subject age, indicating a decrease in adipocyte death 
rate with aging. Females had a lower adipocyte death rate compared to males in both the scABD 
and OM depots, and adipocyte death rate also decreased with increasing BMI, irrespective of 
depots. 
 
We determined lipid age alongside mean adipocyte age in a cohort of 53 subjects for whom 
both scABD and OM fat tissue was collected. No significant difference was found between 
scABD and OM lipid age (3.1 ± 0.9 years vs. 3.2 ± 1.1 years), indicating no regional differences 
in lipid removal rate, across the BMI range studied. A sex-dependent effect on lipid age was 
observed, with lipid age in females significantly higher than in males. Subject age also 
significantly correlated with lipid age, indicating (in accordance with the findings in scABD 
depot in Paper II) that lipid turnover decreases with age. No effect of BMI on lipid age was 
observed. Most subjects in this study, however, were morbidly obese so potential differences 
between lean and obese subjects (as reported in Paper I) cannot be ruled out.   
 
Clinical variables such as sex, age and BMI did not have equal impacts on the dynamics of the 
adipose turnover in obesity. We found that sex had the largest effect on both fat cell and lipid 
age.  
 
4.3.2. Discussion and future perspectives 
Adipocyte and lipid turnover are crucial contributors to the size and distribution of the fat mass65, 
114. We demonstrate that the differences in adipose tissue turnover between scWAT and vWAT 
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may contribute to differences in regional fat distribution. Furthermore, we elucidated that sex-, 
age- and BMI-dependent differences in adipose tissue turnover contribute to fat mass regulation.   
 
Until now, no direct information has been available concerning fat cell turnover dynamics in 
omental adipose tissue; one of the major visceral fat depots in humans that is strongly link to 
metabolic disease. We report here that mean adipocyte age is higher, and thus the death rate is 
lower, in the OM compared to scABD fat depot. If the fat mass is in a steady state, this would 
equate to a decreased adipocyte generation rate in the OM depot. We have shown previously 
that a low adipocyte generation rate is associated with adipose tissue hypertrophy, whereas a 
high generation rate is associated with adipose tissue hyperplasia74. Therefore, the slower 
turnover rate of adipocytes in the OM depot may represent a limitation in the plasticity of vWAT 
to accommodate an increase in energy intake. This then predisposes OM fat cells to respond by 
hypertrophy and increases the risk of ectopic lipid deposition once this limited storage capacity 
is exhausted. This hypertrophic state is known to be linked to an adverse metabolic profile. As 
shown in Paper II, OM adipose tissue maintains a constant lipid turnover rate across a wide 
range of body fat levels, which is only reduced in excessive obesity. scABD adipose tissue 
showed the same pattern, although lipid turnover was already attenuated early in the overweight 
state. Given the majority of subjects in the present study were morbidly obese, our finding that 
lipid removal rate was not significantly different between OM and scABD adipose depots may 
reflect a lack of difference in lipid turnover in severely obese individuals (BMI ≥ 40), as found 
in Paper I. Taken together, these results show that scABD adipose tissue has an increased 
capacity for cell turnover and, in the non-morbidly obese state, an increased capacity to store 
lipid compared to OM adipose tissue. Such differences may underlie the healthy expansion of 
scABD fat, which acts as a safe storage site for TG. Conversely, the reduced capacity of OM 
adipose tissue to undergo hyperplastic expansion in times of lipid excess may promote OM 
adipocyte hypertrophy and the associated metabolic complications. 
 
Substantial differences at multiple levels of metabolic control have been reported between 
males and females, including the amount and distribution of adipose tissue87, 88, 102, 132, 133. We 
report here that both average adipocyte and lipid age are higher in females than in males. The 
slower death rate of fat cells and reduced lipid removal rate in females may account for the 
higher percentage of total body fat generally observed in females87. Sexual dimorphism in body 
fat mass and distribution found in early puberty, as well as the change of body compositions in 
postmenopausal women, have brought much attention to the involvements of sex hormones in 
adipose tissue biology87, 88. Sex hormones mediate their biological actions through nuclear 
receptors on both APs and mature adipocytes, however, many of the regulatory mechanisms 
remain unclear. A lower adipocyte death rate in females may be due to the protective effects of 
estrogen against apoptosis in both APs and mature adipocytes90, 134, potentially contributing to 
a higher mean adipocyte age and higher number of fat cells in females. These characteristics 
may provide females (at least in the pre-menopausal state) more flexibility to accumulate 
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energy and better equip them for the energy demands of pregnancy and lactation. Along with 
reduced adipocyte death rate, lipid removal rate is also decreased in females, which may be 
attributed to a lower adipocyte lipolysis activity in females as reported previously135-137. A 
significant difference in lipid age between females and males was not reported in Paper I, 
which may be due to a poorer representation of males in the previous study (15% males) 
compared to this study (36% males). 
 
Body fat mass increases throughout life, with the increase distributed preferentially to the 
abdominal region compared to lower body fat regions138, 139. This change is associated with an 
increased risk of metabolic disease in the elderly. In line with this, we found that the death rate 
of adipocytes was reduced with aging in the both scABD and OM depots, which in turn may 
promote fat cell accumulation in the abdominal region. Aging had been found to decrease AP 
proliferation and differentiation rates in elderly individuals and increase AP senescence, further 
reducing the proliferation capacity of AP and hence promoting hypertrophic adipose tissue 
expansion139-141. Therefore, a decrease in the death rate of mature adipocytes, along with an 
impaired production rate of new adipocytes, may contribute to a slower adipocyte turnover and 
limited plasticity of adipose tissue for healthy expansion with aging. Changes in lipid turnover 
with age were also reported in Paper II, where the scABD lipid removal rate decreases during 
aging.  We confirm and extend these results in the current study to OM adipose tissue as well. 
Taken together, we demonstrated that a reduced adipocyte death rate and lipid removal rate, 
together promote an increase in abdominal fat mass with age. 
 
When adjusted for depot, sex and age, we found a high BMI was associated with a high 
adipocyte age and low adipocyte death rate. This would, over time, result in an increase in fat 
cell number in obese compared to lean individuals. In a cross-sectional study, where total fat 
cell number in lean and obsess adults was calculated, obese individuals were shown to have a 
two to three-fold increase in number, compared to lean individuals65. In Paper I, differences in 
the lipid removal rate between the scABD and OM fat depots was lost in morbid obesity (Figure 
4.1), which may explain why in this study we did not see an effect of BMI on lipid removal rate 
(56 out of 66 subjects were obese in this study). Unfortunately, there are clear challenges in 
obtaining sufficient amount of fat tissue required for 14C measurement from lean individuals, 
let alone from both the scABD and OM fat depots within the same individual. Therefore, it is a 
limitation of this study that the examined population is skewed towards the morbid obesity.    
 
In summary, we provide the first comprehensive data about the age of omental fat cells in 
humans. Furthermore, we show that alterations in the adipocyte death rate and lipid removal of 
OM and scABD fat depots contribute to differences in regional adiposity. We also demionstrate 
that sex and age are important determinants of adipose tissue turnover dynamics. A better 
understanding of the factors governing body fat accumulation and distribution may lead to the 
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5. CONCLUDING REMARKS 
 
The synthesis and breakdown of adipocytes and lipids control the number and size of fat cells, 
respectively, and thus play a central role in obesity development. In this thesis, I present how 
adipocyte and lipid turnovers differ in scWAT and vWAT, in obese and lean individuals, and 
how this contributes to total fat mass accumulation and distribution. Moreover, how aging and 
sex affect adipose tissue turnover is discussed.  
 
The reduced adipocyte turnover rate in OM adipose tissue demonstrates the limited capacity of 
vWAT to expand by means of hyperplasia, predisposing OM fat cells to respond to excess 
energy by hypertrophic expansion, and thereby promoting ectopic lipid deposition. Lipid 
removal rate decreased both in scWAT and vWAT as BMI increased, however, the removal 
rate in vWAT remained relatively stable over a broad range of BMIs and was only reduced in 
excessive obesity. On the other hand, a reduced lipid removal rate in scWAT occurred already 
earlier in the overweight state. These results suggest that scWAT is the “frontline” storage space 
at obesity onset, and once it reaches the limits of expandability, ectopic lipid deposits into the 
vWAT fat. The limited expandability of vWAT may promote the hypertrophic expansion of 
visceral adipocytes and contribute to ectopic lipid deposition into secondary storage sites, such 
as the liver and muscles. 
 
We showed that the removal rate of adipocytes decreases with aging in both scABD and OM 
fat depots. This contributes to an increase in the fat mass in the abdominal region and 
subsequently central obesity. In line with this, the scABD lipid removal rate also decreases with 
aging. We determined that a failure to reduce lipid intake (which serve as a proxy for food 
intake) over a 13year period results in approximately a 20 percent increase in body weight. 
Interestingly, central obese individuals showed a reduced lipid removal rate, indicating an 
interaction between adipocyte and lipid turnover. We also uncovered fundamental differences 
between females and males in the ways that they turnover their lipids and fat cells, which may 
contribute to the higher body fat percentage generally observed in females. 
 
Based on our results, differences in adipocyte and lipid turnover present a potential treatment 
target for mitigating the metabolic complications associated with obesity and fat mass 
distribution. Understanding the turnover dynamics of adipose tissues in humans gives clearer 
insights into the factors regulating the fat mass in humans. This thesis identifies the factors 
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